Clariant Reports Higher Sales in 2017-18
Speciality chemicals firm, Clariant Chemicals (India) Ltd., has posted net sales of Rs. 1014-crore for the financial year 2017-18 – a growth of 3.4% against the reported sales of Rs. 981-crore for the FY2016-17. The company’s profit before tax stood at Rs. 33.4-crore for the 12 months ended March 31, 2018 as compared to Rs. 36.3-crore for the corresponding year-ago period.
For the quarter ended March 31, 2018, the net sales were at Rs. 244-crore (Rs. 254-crore in the same year-ago period). The profit from operations stood at Rs. 1.9-crore for the quarter (Rs. 10.2-crore). The company said it will continues to focus on raw material and cost management, site optimisation, targeting new markets and introducing innovative products in its drive for sustainable growth.
2026-09-12
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Exit! Why Did Clariant Divest Its Venezuelan Business at a “Low Price”?
-
Clariant and FUHUA Establish Joint Venture to Co-Develop Halogen-Free Flame Retardants
-
Clariant SynDane Catalyst Performs Excellently at Wanhua Maleic Anhydride Plant
-
Clariant and Shanghai Electric Partner to Advance Biomass-Based Green Methanol in China
-
Clariant’s New Aristoflex SUN for Advanced Sunscreen Formulations
-
Lugman Group Exits Acquisition of Clariant's 'Industrial Park Fechenheim'
-
TER Chemicals and Clariant Expand Distribution Partnership into Central and Eastern Europe
-
Clariant achieves 100% PFAS-free additive portfolio
-
Lucas Meyer Cosmetics by Clariant Opens New Beauty ColLABoration House Near Los Angeles
-
Clariant's multifunctional additive production line landed in Hebei, China!
Recommend Reading
-
Pfizer Sues Metsera and Novo Nordisk Over Rival Obesity Drug Strategy
-
Semcorp's Hungarian Factory Ordered to Shut Down Over Pollution
-
Pfizer Seen Holding Strategic Edge in Bidding Battle for Metsera
-
Cipla CEO Calls Tirzepatide a High-Science Product with Strong Market Outlook
-
Novo Nordisk Enters High-Stakes Bidding War with Pfizer for Metsera
-
Double Benefits: Aniline Market Rises Multiple Times
-
Business Society’s Market Outlook for Acrylic Acid on August 17, 2026: Weak Rebound
-
Rise in Chinese Urea Market Prices (1.12-1.16)
-
FDA Names Veteran Oncology Regulator Pazdur as Director of Drug Review Center
-
DMF Market Prices Remain Stable with a Slight Tendency to Strengthen